Witte H, Kunstner A, Hahn T, Bernard V, Stolting S, Kusch K
Ann Hematol. 2025; .
PMID: 39992429
DOI: 10.1007/s00277-025-06274-5.
Shirani N, Abdi N, Chehelgerdi M, Yaghoobi H, Chehelgerdi M
Front Cell Dev Biol. 2025; 13:1485422.
PMID: 39925739
PMC: 11802832.
DOI: 10.3389/fcell.2025.1485422.
van der Merwe N, Buccimazza I, Rossouw B, Araujo M, Ntaita K, Schoeman M
Breast Cancer Res Treat. 2024; 207(2):331-342.
PMID: 38814507
PMC: 11297091.
DOI: 10.1007/s10549-024-07362-2.
Kurochkina N, Sapio M, Iadarola M, Hall B, Kulkarni A
bioRxiv. 2023; .
PMID: 37502949
PMC: 10370197.
DOI: 10.1101/2023.06.21.545989.
Ren Y, Song Z, Rieser J, Ackermann J, Koch I, Lv X
Cancers (Basel). 2023; 15(5).
PMID: 36900163
PMC: 10000201.
DOI: 10.3390/cancers15051371.
BRCA1-associated RING domain-1 (BARD1) loss and GBP1 expression enhance sensitivity to DNA damage in Ewing sarcoma.
Maurer L, Daley J, Mukherjee E, Venier R, Julian C, Bailey N
Cancer Res Commun. 2022; 2(4):220-232.
PMID: 36187937
PMC: 9524505.
DOI: 10.1158/2767-9764.crc-21-0047.
BARD1 mystery: tumor suppressors are cancer susceptibility genes.
Hawsawi Y, Shams A, Theyab A, Abdali W, Hussien N, Alatwi H
BMC Cancer. 2022; 22(1):599.
PMID: 35650591
PMC: 9161512.
DOI: 10.1186/s12885-022-09567-4.
RNA assay identifies a previous misclassification of BARD1 c.1977A>G variant.
Rofes P, Pineda M, Feliubadalo L, Menendez M, de Cid R, Gomez C
Sci Rep. 2021; 11(1):22948.
PMID: 34824355
PMC: 8617171.
DOI: 10.1038/s41598-021-02465-y.
RNF19A-mediated ubiquitination of BARD1 prevents BRCA1/BARD1-dependent homologous recombination.
Zhu Q, Huang J, Huang H, Li H, Yi P, Kloeber J
Nat Commun. 2021; 12(1):6653.
PMID: 34789768
PMC: 8599684.
DOI: 10.1038/s41467-021-27048-3.
Breast Cancer Predisposition Genes and Synthetic Lethality.
Neiger H, Siegler E, Shi Y
Int J Mol Sci. 2021; 22(11).
PMID: 34070674
PMC: 8198377.
DOI: 10.3390/ijms22115614.
Functional consequences of a rare missense BARD1 c.403G>A germline mutation identified in a triple-negative breast cancer patient.
Zheng Y, Li B, Pan D, Cao J, Zhang J, Wang X
Breast Cancer Res. 2021; 23(1):53.
PMID: 33933153
PMC: 8088670.
DOI: 10.1186/s13058-021-01428-5.
SIRT2 promotes BRCA1-BARD1 heterodimerization through deacetylation.
Minten E, Kapoor-Vazirani P, Li C, Zhang H, Balakrishnan K, Yu D
Cell Rep. 2021; 34(13):108921.
PMID: 33789098
PMC: 8108010.
DOI: 10.1016/j.celrep.2021.108921.
A synergetic effect of BARD1 mutations on tumorigenesis.
Li W, Gu X, Liu C, Shi Y, Wang P, Zhang N
Nat Commun. 2021; 12(1):1243.
PMID: 33623049
PMC: 7902612.
DOI: 10.1038/s41467-021-21519-3.
Literature Review of as a Cancer Predisposing Gene with a Focus on Breast and Ovarian Cancers.
Alenezi W, Fierheller C, Recio N, Tonin P
Genes (Basel). 2020; 11(8).
PMID: 32726901
PMC: 7464855.
DOI: 10.3390/genes11080856.
The Function of BARD1 in Centrosome Regulation in Cooperation with BRCA1/OLA1/RACK1.
Otsuka K, Yoshino Y, Qi H, Chiba N
Genes (Basel). 2020; 11(8).
PMID: 32722046
PMC: 7464954.
DOI: 10.3390/genes11080842.
Functional analysis of clinical germline variants.
Toh M, Chong S, Chan S, Low C, Ishak N, Lim J
Cold Spring Harb Mol Case Stud. 2019; 5(4).
PMID: 31371347
PMC: 6672023.
DOI: 10.1101/mcs.a004093.
Genetic Predisposition to Neuroblastoma.
Barr E, Applebaum M
Children (Basel). 2018; 5(9).
PMID: 30200332
PMC: 6162470.
DOI: 10.3390/children5090119.
Ubiquitination and deubiquitination emerge as players in idiopathic pulmonary fibrosis pathogenesis and treatment.
Li S, Zhao J, Shang D, Kass D, Zhao Y
JCI Insight. 2018; 3(10).
PMID: 29769446
PMC: 6012502.
DOI: 10.1172/jci.insight.120362.
Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1.
Zhu Y, Liu Y, Zhang C, Chu J, Wu Y, Li Y
Nat Commun. 2018; 9(1):1595.
PMID: 29686231
PMC: 5913295.
DOI: 10.1038/s41467-018-03951-0.
Transcriptional repression of DNA repair genes is a hallmark and a cause of cellular senescence.
Collin G, Huna A, Warnier M, Flaman J, Bernard D
Cell Death Dis. 2018; 9(3):259.
PMID: 29449545
PMC: 5833687.
DOI: 10.1038/s41419-018-0300-z.